Business Wire: June 26, 2017 – NEWARK, CA, U.S.A. – Icon Bioscience Inc. (IBI), a specialty biopharmaceutical company focused on utilizing its Verisome® drug-delivery platform to develop unique intraocular eye-care therapeutics, today announced that it has received notification from the U.S. Food…
